Br Biomedical Profile
Key Indicators
- Authorised Capital ₹ 12.20 Cr
as on 18-07-2024
- Paid Up Capital ₹ 12.20 Cr
as on 18-07-2024
- Company Age 18 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 30.43 Cr
as on 18-07-2024
- Satisfied Charges ₹ 10.00 Cr
as on 18-07-2024
- Revenue 28.38%
(FY 2023)
- Profit 12.16%
(FY 2023)
- Ebitda -24.55%
(FY 2023)
- Net Worth 662.47%
(FY 2023)
- Total Assets 136.30%
(FY 2023)
About Br Biomedical
The Corporate was formerly known as Br Biomedicals Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 12.20 Cr and a paid-up capital of Rs 12.20 Cr.
The company currently has active open charges totaling ₹30.43 Cr. The company has closed loans amounting to ₹10.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Br Biomedical Private Limited India is Chanchal Sharma as COMPANY SECRETARY. Nitasha Agarwal and Madhav Agarwal serve as directors at the Company.
- CIN/LLPIN
U85121DL2006PTC154502
- Company No.
154502
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Sep 2006
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Br Biomedical?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Chanchal Sharma | Company Secretary | 12-Apr-2024 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nitasha Agarwal  | Director | 19-Nov-2021 | Current |
| Madhav Agarwal | Director | 11-Dec-2018 | Current |
Financial Performance of Br Biomedical.
Br Biomedical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 28.38% increase. The company also saw a substantial improvement in profitability, with a 12.16% increase in profit. The company's net worth Soared by an impressive increase of 662.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Br Biomedical?
In 2023, Br Biomedical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vego & Thomson Infra-Tech (India) Private LimitedActive 2 years 6 monthsNitasha Agarwal and Madhav Agarwal are mutual person
- Vego & Thomson India Private LimitedActive 5 years 1 month
Nitasha Agarwal and Madhav Agarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 08 Jan 2020 | ₹15.00 Cr | Open |
Yes Bank Limited Creation Date: 27 Aug 2018 | ₹15.43 Cr | Open |
Oriental Bank Of Commerce Creation Date: 18 Mar 2014 | ₹1.35 M | Satisfied |
How Many Employees Work at Br Biomedical?
Br Biomedical has a workforce of 14 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Br Biomedical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Br Biomedical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
